| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,817 | 7,442 | ||
| Accounts receivable, net | 12,109 | 11,937 | ||
| Inventories | 21,604 | 22,255 | ||
| Other current assets | 3,275 | 3,335 | ||
| Total current assets | 43,805 | 44,969 | ||
| Property, plant and equipment, net | 4,990 | 4,913 | ||
| Operating lease right-of-use assets | 7,500 | 7,131 | ||
| Goodwill | 9,525 | 10,152 | ||
| Intangible assets, net | 8,379 | 9,139 | ||
| Other long-term assets | 3,793 | 3,789 | ||
| Total assets | 77,992 | 80,093 | ||
| Debt | 33,967 | 34,864 | ||
| Accounts payable | 5,176 | 4,722 | ||
| Contract liabilities | 2,879 | 3,143 | ||
| Other current liabilities | 12,374 | 12,473 | ||
| Total current liabilities | 54,396 | 55,202 | ||
| Deferred tax liability | 733 | 734 | ||
| Operating lease liabilities | 7,332 | 6,997 | ||
| Other long-term liabilities | 1,463 | 1,427 | ||
| Total liabilities | 63,924 | 64,360 | ||
| Common stock, par value 0.01 per share, 80,000,000 shares authorized 44,579,665 shares issued and outstanding at september 30, 2025 44,074,475 shares issued and outstanding at december 31, 2024 | 446 | 445 | ||
| Additional paid-in-capital | 237,922 | 237,622 | ||
| Accumulated deficit | -211,863 | -210,632 | ||
| Accumulated other comprehensive loss | -12,437 | -11,702 | ||
| Total stockholders' equity | 14,068 | 15,733 | ||
| Total liabilities and stockholders' equity | 77,992 | 80,093 | ||
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)